Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomasSilvia Uccella, Stefano Sacchi, Erika Morsia et al.|Human Pathology|2023Cited by 3
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experienceRiccardo Bomben, Valter Gattei, Antonella Zucchetto et al.|HemaSphere|2024Cited by 1
Clinico-Pathological, Cytogenetic and Molecular Similarities and Differences between Primary and Secondary Cutaneous LymphomasSilvia Uccella, Stefano Sacchi, Gaia Goteri et al.|Blood|2022Cited by 0
CD49d Expression Is Included in a Revised 4-Factor Model Predicting Outcome in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Multi-Center Real-World ExperienceRiccardo Bomben, Valter Gattei, Antonella Zucchetto et al.|Blood|2023Cited by 0